Prostate Cancer - Results from #800

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series. May 30, 2024

IL-38 promotes the development of prostate cancer. May 29, 2024

Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI. May 29, 2024

Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts. May 29, 2024

Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study. May 29, 2024

Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card. May 29, 2024

2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience. May 29, 2024

ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESUR. May 29, 2024

Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial. May 29, 2024

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high-grade prostate cancer patients. May 28, 2024

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer. May 28, 2024

Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT. May 28, 2024

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches. May 28, 2024

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. May 28, 2024

CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer. May 28, 2024

A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer. May 28, 2024

Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer. May 27, 2024

PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. May 27, 2024

Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen depr May 27, 2024

Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review. May 27, 2024

Page 41 of 1435